ROBERT CHEN, CPA/MPA

** ******** *****, **********, ** 08536 • 609-***-**** • ad1sxz@r.postjobfree.com

FINANCIAL ACCOUNTING PROFESSIONAL

Leadership in transitioning the Finance Department of a private corporation to a public Nasdaq-listed corporation and 3 times experiences in building start-up pharmaceutical company’s financial, operating, internal control infrastructures from scratch. Effectively lead FP&A & Accounting departments. Leadership in devising strategies for cost reduction and profitability. Leadership in reducing month-end closing from 3 days to 1 day. 20+ years of experience in private (manufacturing) and public financial and cost accounting, SEC filing (10Q & 10K), financial reporting and analysis, budgeting/forecasting, system design and implementation & GTN models. Recipient of an “Outstanding Performance” rating for 10 consecutive years. Passed all 4 parts of CPA exam on first attempt.

PROFESSIONAL EXPERIENCE

TRUE LIGHT WORLDWIDE MINISTRIES, Plainsboro, NJ 03/22-Present Vice President-Finance

Financial consulting on setting up financial infrastructure for start-up pharmaceutical firm.

Budgeting, forecasting, FP&A, month-end closing, cost accounting & Great Plain/Microsoft Dynamic system design & implementation

Gross-to-Net model set-up & training.

ELITE PHARMACEUTICALS, INC. (Niche Generic Products), Northvale, NJ 05/22-02/23 Chief Financial Officer

SEC filings: 10K, 10Q and investor conference calls.

Leadership in training & building up a finance team for Nasdaq listing.

Developed a 5-year budgeting, forecasting & variance analysis.

Leadership in loan management, external audits, IT & HR function.

Leadership in setting up mechanism to implement 3PL service. KBP BIOSCIENCES (Clinical stage 3 biotech start-up), Princeton, NJ 12/20-02/22 Vice President

Leadership of managing US and China financial operations per US GAAP & IFRS.

Led the 5-year global budget preparation & implementation.

Leadership for Internal Control Report & internal audit function required for HK IPO.

Developed mechanism to implement cost reduction for clinical trial phase 3 study.

Served as liaison for effective communication between US & China operations VICTORY COMMERCIA MANAGEMENT, INC., New York, NY 07/19-10/20 Chief Financial Officer

Successfully managed the finance department in order to file 10Q/10K with SEC.

Worked on the corporate goal of taking the company from an OTC listed company to a Nasdaq listed company.

Leadership in building up the financial/accounting teams with operations in US, HK, & China.

Engaged in planning for fund raising in the US & China. WUXI ADVANCED THERAPIES (Gene & Cell Therapies), Phil, PA 1/19-07/19 Sr. Director of Finance

Successfully restructured a CDMO company’s costing & pricing models to enhance gross margin.

Managed FP&A & Accounting departments, & successfully devised a profitability report by customer to identify the drivers for negative margin & map out a path to profitability.

Leadership in identifying cost reduction of $3-4M through savings from internal cross training, material management, & SG&A spending.

TAIHO ONCOLOGY INC. (Colon Cancer Drug), Princeton, NJ Sr. Director of Finance 1/17-10/18

ROBERT CHEN, CPA/MPA

2

Director of Finance 09/14-12/16

Successfully led Taiho Oncology to develop from scratch the financial system, operating infrastructures, closing procedures (including gross-to net model), operating manuals, and internal control and audits in compliance with US GAAP and IFRS.

Effectively managed FP&A & Accounting departments, & restructured Finance staff functions to maximize performance through innovation and system efficiency.

Successfully created a gross-to-net model from scratch for monthly liability accrual (including Medicaid, Medicare, & chargebacks) & monitoring purpose.

Successfully designed a cash flow projection model with minimal variance between actual vs. forecast.

Successfully created a Finance department to function through system design and well-thought-out closing procedures and recording guidance.

Managed the company’s budget, forecast, financial analysis team and present the monthly operation results to the Senior Management.

Effectively hired, trained and led Finance staff to implement detailed steps for financial reporting functions including month-end closing, cash forecasting, gross-to-net, inventory, A/P, A/R, and payroll.

Effectively designed forecasting model on sales, inventory and COGS, and review the calculations of transfer pricing for the raw materials shipped from Japan.

Leadership in motivating Finance team for higher job satisfaction.

Successfully guided one of our pharmaceutical subsidiaries in Canada to establish its financial and operating infrastructures and supervised Taiho’s financial operations in UK.

Reviewed and supervised financial packages based on IFRS to Japan parent company, and acted as a liaison between US subsidiary and Japan accounting and financial transactions.

Served as one of the major document reviewers for the governmental and commercial contracts by Commercial, Medical Affair and Clinical departments.

Supervised external audits and internal audits on Concur reports, identified operational weaknesses, and provided improvement recommendations.

Successfully Led the system design, implementation, installation, and production on Microsoft Dynamics financial accounting system.

MEDIMETRIKS PHARMACEUTICALS INC. (Skin Products), Fairfield, NJ 2010-09/14 Corporate Controller

Successfully devised and established the system flows, internal control, and financial infrastructures for the pharmaceutical startup company.

Effectively restructured Finance staff functions to maximize performance through innovation and system efficiency.

Successfully created a Finance department to function through system design and well-thought-out closing procedures and recording guidance.

Administered general accounting and financial reporting functions including month-end closing, forecasting and budget preparation.

Supervised external audits, identify operational weaknesses, and provide improvement recommendations.

Reviewed and put together 10Q and 10K reports.

Liaised with CIO for new accounting system and EDI implementation. CLARK HOLDING INC., Trenton, NJ 2007-2009

VP and Controller, VP of Finance, Domestic Operations

Successfully led Clark Holding to transition from a private entity to a public Nasdaq-listed corporation.

Successfully revised and enhanced Clark Holding’s financial system, operating infrastructures, closing procedures, operating manuals, and internal control and audits in compliance with US GAAP.

Effectively administered cash, AR/ AP, payroll functions and reviewed filing and calculation of Federal/State ROBERT CHEN, CPA/MPA

3

income and Sales/Use tax.

Successfully managed monthly and quarterly operational budgets and rolling forecasts.

Monitored system controls and established policies to ensure SOX compliance.

Created models and utilized analytics to monitor business profitability.

Redesigned and implemented recording procedures and account reconciliations for timely closings and 10Q/K filings.

Recruited, trained, and oversaw the performance of the Accounting Manager and personnel. NOVARTIS PHARMACEUTICAL INC., East Hanover, NJ 2007 Associate Director

Managed month-end closing, internal control, and SOX compliance and documentation.

Utilized Business Warehouse (BW) to extract data from SAP and combined them with 852 data to automate the Chargeback Pipeline Model calculations.

Analyzed Chargeback, Medicaid, Managed Care and Part D Pipeline Models and presented recommendations for improvements.

BRADLEY PHARMACEUTICALS INC. (Therapeutic & skin Products), Fairfield, NJ 1998-2007 Corporate Controller

Successfully Administered financial accounting with annual revenue of $200 million.

Managed monthly closings, reporting, operation results and SG&A analysis.

Liaised with CFO to plan/supervise external audits, 10Q/10K filing and press releases.

Reviewed testing and documentation for SOX requirements.

Reduced month-end closing from 45 to 7 days by enhancing system design and recording efficiency.

Generated comprehensive Product/Country P&L Analysis reports to determine brand promotions.

Successfully coordinated with IT to integrate the financial systems of Bioglan Pharmaceuticals, a newly acquired corporation.

FORMOSA PLASTICS CORPORATION, USA, Livingston, NJ 1992 – 1998 Plant Controller/Corporate Cost/General Accounting Manager

Successfully managed monthly closing with detailed analysis in a privately held petrochemical conglomerate/manufacturer with 5 billion in annual sales.

Effectively trained Plant Personnel/Controllers on Corporate Cost Accounting and G/L Systems.

Effectively developed and implemented closing procedures for plants and subsidiaries.

Key member of team which reduced month-end closing time from three days to one day in 3 years.

Collaborated with Corporate Controller to centralize A/P and Cost Accounting functions in Headquarters Accounting Department, resulting in cost reductions and reporting efficiency.

Implemented integration of Freight, Shipping and EDI Payment Systems.

Provided detailed analysis of operations results and statement of cash flow three days following the closing. PRICE WATERHOUSE, Houston, TX 1990 – 1992

Industrial Financial Analyst

Developed merger and acquisition proposals to establish target selection, identify potential targets, and assess preliminary feasibility.

Analyzed petroleum industry trends and developments to report on new practice opportunities.

Analyzed and presented operation reports on 40 major firms in the Oilfield Service and Supply Industry. AMOCO CORPORATION, Tulsa, OK 1989 – 1990

Professional Accountant

ROBERT CHEN, CPA/MPA

4

EDUCATION AND TRAINING

BSBA, Accounting, University of Southern Mississippi, Hattiesburg, MS 1987 MPA, Master of Professional Accountancy, University of Southern Mississippi, Hattiesburg, MS 1989 Computer skills: AS 400, Quickbook, Netsuite ERP, Microsoft Dynamics, SAP Business Solution

Contact this candidate